Navigation Links
Cystic Fibrosis - Liposomal Tobramycin Receives Second Orphan Drug Designation Within Weeks

ystem with already established and well-characterized therapeutic agents. The company is using its platform delivery technology, named Fluidosomes(TM) technology, for the development of its lead product, an inhalable liposomal formulation of tobramycin. Axentis Pharma's lead product is designed to treat bacterial infections in the lungs.

About Fluidosomes(TM) technology

Axentis Pharma's Fluidosomes(TM) technology uses biocompatible lipids endogenous to the lung that are formulated into small liposomes. This nanocapsule platform offers wide-ranging potential for unmet medical needs, including chronic respiratory infections of the lung. In the case of Fluidosomes(TM)-tobramycin, the interaction between tobramycin and the microbial cell is triggered when the liposomes undergo a fusion process with the outer membrane of the bacterial cell wall. Tobramycin then penetrates into the inner cell compartment and triggers bacterial cell death.

    For further information, please contact:
    Dr. Helmut Brunar, Ph.D., CEO
    Axentis Pharma AG
    Limmatquai 138
    8001 Zurich, Switzerland
    T +41-44-202-7878

    Copy Editing & Distribution:
    PR&D - Public Relations for Research & Education
    Campus Vienna Biocenter 2
    1030 Vienna, Austria
    T +43-1-505-70-44

SOURCE Axentis Pharma AG
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Promising Cystic Fibrosis Compound on Track for Development
2. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
3. Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis
4. Cystic Fibrosis Foundation Reports Upward Trend for Key Health Outcomes
5. Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF
6. Lung Transplants in Cystic Fibrosis Patients With Life-Threatening Bacteria Sparks Debate at ISHLT Meeting
7. PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis
8. PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity
9. Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections
10. Mpex Initiates a Phase 2 Clinical Trial of Aerosol MP-376 in the Treatment of Chronic Bacterial Infections in Cystic Fibrosis Patients
11. The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis
Post Your Comments:
(Date:8/1/2014)... Minn. , Aug. 1, 2014 ... medical technologies company, announced today that it has ... held manufacturer of cardiorespiratory diagnostic products based in ... MediSoft has served the European cardiorespiratory diagnostics market ... 2013 revenues of approximately €4.7 million ($6.3 million) ...
(Date:8/1/2014)... 1, 2014 Dyadic International, Inc. ("Dyadic") (OTCQX: ... technologies are used to develop, manufacture and sell enzymes ... and industrial enzyme industries, announced today that it will ... June 30, 2014 after market close on Thursday, August ... day at 5:00 p.m. Eastern Time to discuss those ...
(Date:7/31/2014)... 2014  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ; ... , Chief Business Officer and Executive Vice President. Mr. Singh ... 30. "Sorrento is deeply saddened and shocked by ... thoughts go to Amar,s family and friends," said Henry ... Mr. Singh joined Sorrento in January 2014 from ...
Breaking Medicine Technology:MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 2MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 3MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 4Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 2Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 3Sorrento Announces the Unexpected Death of its Chief Business Officer 2
... Oct. 8 Breast-Specific Gamma Imaging (BSGI), a molecular ... resonance imaging (MRI) for detecting breast carcinoma when used ... and is substantially less expensive than MRI, according to ... Oncology Breast Cancer Symposium in San Francisco, California. , ...
... Calif., Oct. 8 Endologix, Inc. (Nasdaq: ELGX ), ... that it has become aware that Cook Medical has filed ... alleging that Endologix infringes two of Cook,s U.S. patents. , ... have just become aware of the lawsuit filed by Cook ...
Cached Medicine Technology:Breast-Specific Gamma Imaging Proves Cost-Effective for Pre-Surgical Planning of Patients with Known Cancer Diagnosis 2Endologix Comments on Alleged Patent Infringement 2
(Date:8/1/2014)... NY (PRWEB) August 01, 2014 Ticket Down ... at Maple Lane Farms in Knoxville/Greenback, TN; Ingram Farms ... Whitehurst Cattle Farm in Archer/Gainesville, FL. Luke Bryan is currently ... with Lee Brice and Cole Swindell. Bryan is responsible for ... world each summer and this year, just because the summer ...
(Date:8/1/2014)... at the Institute of Bioengineering and Nanotechnology (IBN), ... Singapore (NCCS) have co-developed the first molecular test ... in kidney cancer patients. This breakthrough was recently ... top urology journal. , According to IBN ... our expertise in molecular diagnostics and cancer research, ...
(Date:8/1/2014)... CapsCanada, a leading provider of ... new K-CAPS® (HPMC capsules) manufacturing facility in Lakeshore, ... last year while experiencing growing global demand for ... “KCAPS® are currently sold in more than 60 ... to other HPMC capsules, K-CAPS® have exceptional appearance ...
(Date:8/1/2014)... Hills, CA (PRWEB) August 01, 2014 ... has found that carbohydrates may contribute to the ... genetically predisposed to the disease. The study was authored ... it, carbohydrates were found to cause intestinal cells to ... more susceptible to colorectal cancer. , “What’s interesting ...
(Date:8/1/2014)... South Jordan, Utah (PRWEB) August 01, 2014 ... selling company MonaVie, who completes its 500th week of ... paid since the company was founded in January 2005 ... 39 countries throughout the world. The company pays commissions ... HKD, HUF, ILS, JPY, MYR, MXN, NZD, PLN, USD, ...
Breaking Medicine News(10 mins):Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 2Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 3Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 4Health News:Taking the guesswork out of cancer therapy 2Health News:Taking the guesswork out of cancer therapy 3Health News:Carbs May Contribute to Colon Cancer 2Health News:MonaVie Records 500th Commission Week, Having Paid Out More Than $1.4B in Distributor Commissions 2
... mice has found that though they do not develop zits, ... to differentiate the cells// in the sebaceous glands that are ... sebaceous gland is formed. ,In new research, published ... Howard Hughes Medical Institute investigator at Rockefeller University, settles this ...
... review of the performance of the 14 boards against ... nutritional care finds// too little progress is being made ... had issued advice including recommendations that patients should be ... 24 hours of being admitted following concerns about the ...
... amounts of soda and sugary drinks is making the ... Hu and his colleagues at the Harvard School of ... conducted over the last 40 years. ,They ... American diet come from added sweeteners. And sweeteners in ...
... second-year students at Wake Forest University School of Medicine ... nervous system. Instead, a semi-conscious,// vomiting “patient” was rolled ... to help manage the case. ,“SimMan?,” a ... typical mannequin. The simulated patient makes realistic heart, lung, ...
... Text messages between lovers was imitated by a government AIDS ... highest HIV rates. This enraged activists// who feel it suggests ... ,Pictures of a mobile phone screen bearing text messages like ... over now, my husband is out' features in the 'Makhwapheni ...
... local newspaper, Vietnam News, inns are to be allowed to sell ... ,As a measure to reduce risks, Vietnam will allow the sales ... come into effect from Jan. 1, 2007. Presently, condom sales and ... in many of these inns. ,Apart from the prostitutes ...
Cached Medicine News:Health News:'Blimp1' Gene Linked To Oily Skin 2Health News:Computerized Patient Used to Teach Science to Medical Students 2Health News:AIDS Campaign Enrages HIV Infected Swazis 2
The Ultima 2000 SE is flexible in meeting the needs of both office and operating room use. It is the answer for the clinical practice with a wide range of ophthalmic demands looking for minimal risk ...
Practice-oriented ophthalmic laser systems for photodisruption....
Magnetic Farnsworth D15 kit Magnets move the color disks. Protects disks from fingerprints. Keeps all the disks in one place. Clear glass insures accurate color perception. Makes color testing fun....
... D15 test is used to ... defect vs normal. Farnsworth D15 ... permit the patient to select ... the box is closed and ...
Medicine Products: